vitamin k 3 has been researched along with Cancer of Mouth in 1 studies
Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral cancer is one of the most commonly occurring cancers worldwide, decreasing the patient's survival rate due to tumor recurrence and metastasis." | 1.39 | Menadione (Vitamin K3) induces apoptosis of human oral cancer cells and reduces their metastatic potential by modulating the expression of epithelial to mesenchymal transition markers and inhibiting migration. ( Karunagaran, D; Raghu, D; Suresh, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suresh, S | 1 |
| Raghu, D | 1 |
| Karunagaran, D | 1 |
1 other study available for vitamin k 3 and Cancer of Mouth
| Article | Year |
|---|---|
Menadione (Vitamin K3) induces apoptosis of human oral cancer cells and reduces their metastatic potential by modulating the expression of epithelial to mesenchymal transition markers and inhibiting migration.
Topics: Antifibrinolytic Agents; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cadherins; Carcinoma, Squa | 2013 |